Please wait...
Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:
No
52% of Medicare Part D and Medicare Advantage plans cover this drug, so it's pretty much a toss-up.It depends. Which coverage stage are you in? Click on a tab below…
$5 – $125
In the Deductible co-pay stage, you are responsible for the full cost of your prescriptions. Your Medicare deductible cannot exceed $360 in 2016.
Here are some ways that may lower the cost of your lumigan prescription.
If your Medicare co-pay is higher, you can save money by using a USARx coupon instead.
Lumigan (bimatoprost) lowers pressure in the eye by increasing the amount of fluid that drains from the eye.
Lumigan eye drops are used to treat certain types of glaucoma and other causes of high pressure inside the eye.
Lumigan may also be used for purposes not listed in this medication guide.
Do not use Lumigan eye drops while wearing contact lenses. The eye drops may contain a preservative that can discolor soft contact lenses. Wait at least 15 minutes after using Lumigan before putting in your contact lenses.
Lumigan may cause a gradual change in the color of your eyes or eyelids and lashes, as well as increased growth or thickness of your eyelashes. These color changes, usually an increase in brown pigment, occur slowly and you may not notice them for months or years. Color changes may be permanent even after your treatment ends, and may occur only in the eye being treated. This could result in a cosmetic difference in eye or eyelash color from one eye to the other.
Do not allow the tip of the Lumigan eye dropper to touch any surface, including your eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.
After using Lumigan, wait at least 5 minutes before using any other eye drops that your doctor has prescribed.
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
You should not use Lumigan if you are allergic to bimatoprost.
To make sure Lumigan is safe for you, tell your doctor if you have ever had:
swelling or infection in your eye;
retinal detachment; or
eye surgery or injury affecting the lens of your eye.
Lumigan may cause a gradual change in the color of your eyes. You may also notice increased growth or thickness of your eyelashes. These changes occur slowly and you may not notice them for months or years. Color changes may be permanent even after your treatment ends, and may occur only in the eye being treated. This could result in a cosmetic difference in eye or eyelash color from one eye to the other.
It is not known whether Lumigan will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
It is not known whether Lumigan passes into breast milk or if it could affect the nursing baby. Tell your doctor if you are breast-feeding.
Lumigan is not approved for use by anyone younger than 16 years old.
Use Lumigan eye drops exactly as prescribed by your doctor. Follow all directions on your prescription label. Do not use this medicine in larger or smaller amounts or for longer than recommended.
The usual dose of Lumigan eye drops is 1 drop into the affected eye every evening. Follow your doctor's dosing instructions very carefully.
Do not use this medicine while wearing contact lenses. Lumigan may contain a preservative that can discolor soft contact lenses. Wait at least 15 minutes after using this medicine before putting in your contact lenses.
Wash your hands before using the eye drops.
To apply the Lumigan eye drops:
Tilt your head back slightly and pull down your lower eyelid to create a small pocket. Hold the dropper above the eye with the tip down. Look up and away from the dropper and squeeze out a drop.
Close your eyes for 2 or 3 minutes with your head tipped down, without blinking or squinting. Gently press your finger to the inside corner of the eye for about 1 minute, to keep the liquid from draining into your tear duct.
Wait at least 5 minutes before using any other eye drops your doctor has prescribed.
Do not touch the tip of the eye dropper or place it directly on your eye. A contaminated dropper can infect your eye, which could lead to serious vision problems.
Do not use Lumigan eye drops if the liquid has changed color or has particles in it. Call your pharmacist for new medicine.
Tell your doctor right away if you have an eye injury or eye infection, or if you plan to have eye surgery.
Store this medicine at cool room temperature, away from moisture and heat. Keep the bottle tightly closed when not in use.
Skip the missed dose and use the medicine at the next regularly scheduled time. Do not use extra medicine to make up the missed dose.
An overdose of Lumigan is not expected to be dangerous. Seek emergency medical attention or call the Poison Help line at 1-800-222-1222 if anyone has accidentally swallowed the medication.
Avoid using too much of this medicine, which can actually make it less effective in lowering the pressure inside the eye.
Get emergency medical help if you have signs of an allergic reaction ro Lumigan: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using this medicine and call your doctor at once if you have:
eye swelling, redness, severe discomfort, crusting or drainage (may be signs of infection);
vision changes; or
red, swollen, or itchy eyelids.
Common Lumigan side effects may include:
eye redness or itching.
Lumigan may cause a gradual change in the color of your eyes. You may also notice increased growth or thickness of your eyelashes. These changes occur slowly and you may not notice them for months or years. Color changes may be permanent even after your treatment ends, and may occur only in the eye being treated. This could result in a cosmetic difference in eye or eyelash color from one eye to the other.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
It is not likely that other drugs you take orally or inject will have an effect on Lumigan used in the eyes. But many drugs can interact with each other. Tell each of your healthcare providers about all medicines you use, including prescription and over-the-counter medicines, vitamins, and herbal products.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Lumigan only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/1/2020.
Source: Drugs.com Lumigan (www.drugs.com/lumigan.html).
Note: This document contains side effect information about bimatoprost ophthalmic. Some of the dosage forms listed on this page may not apply to the brand name Lumigan.
Common side effects of Lumigan include: hypertrichosis of eyelid. See below for a comprehensive list of adverse effects.
Applies to bimatoprost ophthalmic: ophthalmic solution
Along with its needed effects, bimatoprost ophthalmic (the active ingredient contained in Lumigan) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking bimatoprost ophthalmic:
Less common
Some side effects of bimatoprost ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
Less common
Applies to bimatoprost ophthalmic: ophthalmic solution
The most frequently reported adverse reactions were eyelash growth, conjunctival hyperemia, and ocular pruritus.
Very common (10% or more): Growth of eyelashes (up to 45%), conjunctival hyperemia (up to 44%), ocular pruritus (up to 15%)
Common (1% to 10%): Allergic conjunctivitis, asthenopia, blepharitis, blurred vision, cataract, conjunctival edema, conjunctival hemorrhage, corneal erosion, dry eye, eye discharge, eye irritation, eye pain, eye pruritus, eyelash darkening, eyelid pruritus, foreign body sensation, increased iris pigmentation, lacrimation increased, ocular burning, ocular dryness, ocular irritation, photophobia, punctate keratitis, superficial punctate keratitis, tearing, visual disturbance, worsening of visual acuity
Uncommon (0.1% to 1%): Blepharospasm, eyelid edema, eyelid margin crusting, eyelid retraction, iris hyperpigmentation, iritis, retinal hemorrhage, uveitis
Rare (0.01% to 0.1%): Corneal calcification
Frequency not reported: Blepharal pigmentation, cystoid macular edema, eye edema, eyelash changes, eyelid sulcus deepening, intraocular inflammation, macular edema, signs/symptoms of eye allergy
Postmarketing reports: Enophthalmos
Corneal calcification occurred in patients with significant corneal damage using formulations containing phosphate.
Common (1% to 10%): Eyelid erythema, hirsutism, hypertrichosis, periocular skin hyperpigmentation, periorbital erythema, pigmentation of periocular skin, skin hyperpigmentation
Uncommon (0.1% to 1%): Abnormal hair growth, dry skin, madarosis, pruritus
Frequency not reported: Lid changes, periorbital changes, pigmentation, signs/symptoms of allergic dermatitis
Common (1% to 10%): Colds, infections
Common (1% to 10%): Upper respiratory tract infections
Frequency not reported: Asthma, asthma exacerbation, chronic obstructive pulmonary disease (COPD) exacerbation, dyspnea
Postmarketing reports: Asthma-like symptoms
Common (1% to 10%): Headache
Uncommon (0.1% to 1%): Dizziness, vertigo
Common (1% to 10%): Instillation site irritation
Common (1% to 10%): Abnormal liver function tests
Uncommon (0.1% to 1%): Asthenia
Common (1% to 10%): Hypertension
Uncommon (0.1% to 1%): Nausea
Uncommon (0.1% to 1%): Depression
Frequency not reported: Hypersensitivity, hypersensitivity reaction
Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/1/2020.
Source: Drugs.com Lumigan (www.drugs.com/lumigan.html).
March 28, 2020
March 28, 2020
March 28, 2020
March 28, 2020
March 28, 2020
March 28, 2020
